time scales18 Oct 2021 16:45
As I recall with MTFB after their CRL , a meeting with FDA was requested, that took about 3mths, then nothing happened until the minutes from the meeting were received - another month ; then another meeting supplying data, wait for minutes.
It took about 6mths to find out, finally, that the drug could not go ahead.
This is different in that the problem seems to be technical/manufacturing. But NB there were issues (plural) to be addressed and the issues, as per RNS, were ''mainly'' technical and manufacturing.
Could do with an RNS to set out plan to re-submit but I suspect the first steps, as outlined above, will have to be taken and it will take time.
AIM is not a patient market